These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12355562)

  • 1. In vivo effect of 5- and 8-methoxypsoralens and cimetidine on R,S-warfarin metabolism in rat.
    Szutowski MM; Łukasik M; Wawer ZT; Chrobak K; Michalska M; Borzecka K; Brzeziński J
    J Appl Toxicol; 2002; 22(5):327-32. PubMed ID: 12355562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effect of diallyl sulfide and cimetidine on phenacetin metabolism and bioavailability in rat.
    Szutowski MM; Zalewska K; Jadczak M; Marek M
    Acta Biochim Pol; 2002; 49(1):249-56. PubMed ID: 12136947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited sampling strategy of S-warfarin concentrations, but not warfarin S/R ratios, accurately predicts S-warfarin AUC during baseline and inhibition in CYP2C9 extensive metabolizers.
    Ma JD; Nafziger AN; Kashuba AD; Kim MJ; Gaedigk A; Rowland E; Kim JS; Bertino JS
    J Clin Pharmacol; 2004 Jun; 44(6):570-6. PubMed ID: 15145963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats.
    Boralli VB; Coelho EB; Lanchote VL
    Chirality; 2009 Nov; 21(10):886-93. PubMed ID: 19161215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone.
    Takahashi H; Sato T; Shimoyama Y; Shioda N; Shimizu T; Kubo S; Tamura N; Tainaka H; Yasumori T; Echizen H
    Clin Pharmacol Ther; 1999 Dec; 66(6):569-81. PubMed ID: 10613612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates.
    Lemma GL; Wang Z; Hamman MA; Zaheer NA; Gorski JC; Hall SD
    Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of casopitant, a novel NK-1 receptor antagonist, on the pharmacokinetics and pharmacodynamics of steady-state warfarin.
    Kirby LC; Johnson BM; Adams LM; Eberwein DJ; Zhang K; Murray SC; Lates CD; Blum RA; Morris SR
    J Clin Pharmacol; 2010 May; 50(5):566-75. PubMed ID: 20220045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of a pharmacokinetic interaction between etanercept and warfarin.
    Zhou H; Patat A; Parks V; Buckwalter M; Metzger D; Korth-Bradley J
    J Clin Pharmacol; 2004 May; 44(5):543-50. PubMed ID: 15102876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in pharmacokinetics of oral warfarin in rats.
    Zhu X; Shin WG
    Biopharm Drug Dispos; 2005 May; 26(4):147-50. PubMed ID: 15776499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients.
    McAleer SD; Foondun AS; Feely M; Chrystyn H
    Chirality; 1997; 9(1):13-6. PubMed ID: 9094197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 5-methoxypsoralen (5-MOP) on arylamine N-acetyltransferase activity in the stomach and colon of rats and human stomach and colon tumor cell lines.
    Lee YM; Wu TH
    In Vivo; 2005; 19(6):1061-9. PubMed ID: 16277023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of pharmacokinetic and pharmacodynamic interactions between a smoking cessation therapy, varenicline, and warfarin: an in vivo and in vitro study.
    Burstein AH; Clark DJ; O'Gorman M; Willavize SA; Brayman TG; Grover GS; Walsky RL; Obach RS; Faessel HM
    J Clin Pharmacol; 2007 Nov; 47(11):1421-9. PubMed ID: 17962429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of warfarin metabolism by diltiazem in humans.
    Abernethy DR; Kaminsky LS; Dickinson TH
    J Pharmacol Exp Ther; 1991 Apr; 257(1):411-5. PubMed ID: 2020000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance.
    Takahashi H; Kashima T; Kimura S; Murata N; Takaba T; Iwade K; Abe T; Tainaka H; Yasumori T; Echizen aH
    Drug Metab Dispos; 1999 Oct; 27(10):1179-86. PubMed ID: 10497145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the pharmacokinetics and pharmacodynamics of warfarin.
    Schwartz JI; Liu F; Stroh M; Gipson A; Johnson-Levonas AO; Lasseter KC; Lai E; Wagner JA
    Am J Ther; 2009; 16(3):215-23. PubMed ID: 19454860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766.
    Oberwittler H; Hirschfeld-Warneken A; Wesch R; Willerich H; Teichert L; Lehr KH; Ding R; Haefeli WE; Mikus G
    J Clin Pharmacol; 2007 Jan; 47(1):70-7. PubMed ID: 17192504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):72-9. PubMed ID: 6491976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of 5-methoxypsoralen affects the distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats.
    Lee YM; Chen SF; Li YC; Lin SS; Chung JG
    In Vivo; 2002; 16(3):201-13. PubMed ID: 12182117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.